Cited by — Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis.
No admitted local citation edges point to this work yet.